Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2013

Open Access 01-12-2013 | Research article

Risk factors for incident hyperuricemia during mid-adulthood in African American and White men and women enrolled in the ARIC cohort study

Authors: Mara A McAdams-DeMarco, Andrew Law, Janet W Maynard, Josef Coresh, Alan N Baer

Published in: BMC Musculoskeletal Disorders | Issue 1/2013

Login to get access

Abstract

Background

Increased serum urate levels are associated with poor outcomes including but not limited to gout. It is unclear whether serum urate levels are the sole predictor of incident hyperuricemia or whether demographic and clinical risk factors also predict the development of hyperuricemia. The goal of this study was to identify risk factors for incident hyperuricemia over 9 years in a population-based study, ARIC.

Methods

ARIC recruited individuals from 4 US communities; 8,342 participants who had urate levels <7.0 mg/dL were included in this analysis. Risk factors (including baseline, 3-year, and change in urate level over 3 years) for 9-year incident hyperuricemia (urate level of > 7.0 g/dL) were identified using an AIC-based selection approach in a modified Poisson regression model.

Results

The 9-year cumulative incidence of hyperuricemia was 4%; men = 5%; women = 3%; African Americans = 6% and whites = 3%. The adjusted model included 9 predictors for incident hyperuricemia over 9 years: male sex (RR = 1.73 95% CI: 1.36-2.21), African-American race (RR = 1.79 95% CI: 1.37-2.33), smoking (RR = 1.27, 95% CI: 0.97-1.67), <HS education (RR = 1.27, 95% CI: 0.99-1.63), hypertension (RR = 1.65, 95% CI: 1.30-2.09), CHD (RR = 1.57, 95% CI: 0.99-2.50), obesity (class I RR = 2.37, 95% CI: 1.65-3.41 and ≥ class II RR = 3.47, 95% CI: 2.33-5.18), eGFR < 60 (RR = 2.85, 95% CI: 1.62-5.01) and triglycerides (Quartile 4 vs. Quartile 1: RR = 2.00, 95% CI: 1.38-2.89). In separate models, urate levels at baseline (RR 1 mg/dL increase = 2.33, 95% CI: 1.94-2.80) and 3 years after baseline (RR for a 1 mg/dL increase = 1.92, 95% CI: 1.78-2.07) were associated with incident hyperuricemia after accounting for demographic and clinical risk factors.

Conclusion

Demographic and clinical risk factors that are routinely collected as part of regular medical care are jointly associated with the development of hyperuricemia.
Literature
1.
go back to reference Campion EW, Glynn RJ, DeLabry LO: Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987, 82 (3): 421-426. 10.1016/0002-9343(87)90441-4.CrossRefPubMed Campion EW, Glynn RJ, DeLabry LO: Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987, 82 (3): 421-426. 10.1016/0002-9343(87)90441-4.CrossRefPubMed
2.
go back to reference Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O: Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol. 2012, 176 (2): 108-116. 10.1093/aje/kws002.CrossRefPubMed Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O: Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol. 2012, 176 (2): 108-116. 10.1093/aje/kws002.CrossRefPubMed
3.
go back to reference Liu WC, Hung CC, Chen SC, Yeh SM, Lin MY, Chiu YW, Kuo MC, Chang JM, Hwang SJ, Chen HC: Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2012, 7 (4): 541-548. 10.2215/CJN.09420911.CrossRefPubMed Liu WC, Hung CC, Chen SC, Yeh SM, Lin MY, Chiu YW, Kuo MC, Chang JM, Hwang SJ, Chen HC: Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2012, 7 (4): 541-548. 10.2215/CJN.09420911.CrossRefPubMed
4.
go back to reference Tomita M, Mizuno S, Yamanaka H, Hosoda Y, Sakuma K, Matuoka Y, Odaka M, Yamaguchi M, Yosida H, Morisawa H: Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol. 2000, 10 (6): 403-409. 10.2188/jea.10.403.CrossRefPubMed Tomita M, Mizuno S, Yamanaka H, Hosoda Y, Sakuma K, Matuoka Y, Odaka M, Yamaguchi M, Yosida H, Morisawa H: Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol. 2000, 10 (6): 403-409. 10.2188/jea.10.403.CrossRefPubMed
5.
go back to reference Krishnan E, Hariri A, Dabbous O, Pandya BJ: Hyperuricemia and the echocardiographic measures of myocardial dysfunction. Congest Heart Fail. 2012, 18 (3): 138-143. 10.1111/j.1751-7133.2011.00259.x.CrossRefPubMed Krishnan E, Hariri A, Dabbous O, Pandya BJ: Hyperuricemia and the echocardiographic measures of myocardial dysfunction. Congest Heart Fail. 2012, 18 (3): 138-143. 10.1111/j.1751-7133.2011.00259.x.CrossRefPubMed
6.
go back to reference Chiou WK, Huang DH, Wang MH, Lee YJ, Lin JD: Significance and association of serum uric acid (UA) levels with components of metabolic syndrome (MS) in the elderly. Arch Gerontol Geriatr. 2012, 55 (3): 724-728. 10.1016/j.archger.2012.03.004.CrossRefPubMed Chiou WK, Huang DH, Wang MH, Lee YJ, Lin JD: Significance and association of serum uric acid (UA) levels with components of metabolic syndrome (MS) in the elderly. Arch Gerontol Geriatr. 2012, 55 (3): 724-728. 10.1016/j.archger.2012.03.004.CrossRefPubMed
7.
go back to reference Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C: Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. 2012, 41 (3): 450-457. 10.1007/s12020-012-9629-8.CrossRefPubMed Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C: Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. 2012, 41 (3): 450-457. 10.1007/s12020-012-9629-8.CrossRefPubMed
8.
go back to reference Lapsia V, Johnson RJ, Dass B, Shimada M, Kambhampati G, Ejaz NI, Arif AA, Ejaz AA: Elevated uric acid increases the risk for acute kidney injury. Am J Med. 2012, 125 (3): 302 e309-317-CrossRef Lapsia V, Johnson RJ, Dass B, Shimada M, Kambhampati G, Ejaz NI, Arif AA, Ejaz AA: Elevated uric acid increases the risk for acute kidney injury. Am J Med. 2012, 125 (3): 302 e309-317-CrossRef
9.
go back to reference Chuang SY, Chen JH, Yeh WT, Wu CC, Pan WH: Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort. Int J Cardiol. 2012, 154 (3): 316-321. 10.1016/j.ijcard.2011.06.055.CrossRefPubMed Chuang SY, Chen JH, Yeh WT, Wu CC, Pan WH: Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort. Int J Cardiol. 2012, 154 (3): 316-321. 10.1016/j.ijcard.2011.06.055.CrossRefPubMed
10.
go back to reference Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA: Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthrit Care Res. 2010, 62 (2): 170-180. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA: Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthrit Care Res. 2010, 62 (2): 170-180.
11.
go back to reference Gaffo AL, Jacobs DR, Sijtsma F, Lewis CE, Mikuls TR, Saag KG: Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort. Ann Rheum Dis. 2012, 72 (28): 1321-1327.PubMedPubMedCentral Gaffo AL, Jacobs DR, Sijtsma F, Lewis CE, Mikuls TR, Saag KG: Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort. Ann Rheum Dis. 2012, 72 (28): 1321-1327.PubMedPubMedCentral
12.
go back to reference Gaffo AL, Jacobs DR, Lewis CE, Mikuls TR, Saag KG: Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort. Arthrit Res Therapy. 2012, 14 (1): R4-10.1186/ar3552.CrossRef Gaffo AL, Jacobs DR, Lewis CE, Mikuls TR, Saag KG: Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort. Arthrit Res Therapy. 2012, 14 (1): R4-10.1186/ar3552.CrossRef
13.
go back to reference Hak AE, Choi HK: Menopause, postmenopausal hormone use and serum uric acid levels in US women–the Third National Health and Nutrition Examination Survey. Arthrit Res Therapy. 2008, 10 (5): R116-10.1186/ar2519.CrossRef Hak AE, Choi HK: Menopause, postmenopausal hormone use and serum uric acid levels in US women–the Third National Health and Nutrition Examination Survey. Arthrit Res Therapy. 2008, 10 (5): R116-10.1186/ar2519.CrossRef
14.
go back to reference Stockl D, Doring A, Thorand B, Heier M, Belcredi P, Meisinger C: Reproductive factors and serum uric acid levels in females from the general population: the KORA F4 study. PLoS One. 2012, 7 (3): e32668-10.1371/journal.pone.0032668.CrossRefPubMedPubMedCentral Stockl D, Doring A, Thorand B, Heier M, Belcredi P, Meisinger C: Reproductive factors and serum uric acid levels in females from the general population: the KORA F4 study. PLoS One. 2012, 7 (3): e32668-10.1371/journal.pone.0032668.CrossRefPubMedPubMedCentral
15.
go back to reference Choi HK, Curhan G: Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2004, 51 (6): 1023-1029. 10.1002/art.20821.CrossRefPubMed Choi HK, Curhan G: Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2004, 51 (6): 1023-1029. 10.1002/art.20821.CrossRefPubMed
16.
go back to reference Choi HK, Liu S, Curhan G: Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005, 52 (1): 283-289. 10.1002/art.20761.CrossRefPubMed Choi HK, Liu S, Curhan G: Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005, 52 (1): 283-289. 10.1002/art.20761.CrossRefPubMed
17.
go back to reference Gaffo AL, Roseman JM, Jacobs DR, Lewis CE, Shikany JM, Mikuls TR, Jolly PE, Saag KG: Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Ann Rheum Dis. 2010, 69 (11): 1965-1970. 10.1136/ard.2010.129429.CrossRefPubMed Gaffo AL, Roseman JM, Jacobs DR, Lewis CE, Shikany JM, Mikuls TR, Jolly PE, Saag KG: Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Ann Rheum Dis. 2010, 69 (11): 1965-1970. 10.1136/ard.2010.129429.CrossRefPubMed
18.
go back to reference Thompson FE, McNeel TS, Dowling EC, Midthune D, Morrissette M, Zeruto CA: Interrelationships of added sugars intake, socioeconomic status, and race/ethnicity in adults in the United States: National Health Interview Survey, 2005. J Am Diet Assoc. 2009, 109 (8): 1376-1383. 10.1016/j.jada.2009.05.002.CrossRefPubMedPubMedCentral Thompson FE, McNeel TS, Dowling EC, Midthune D, Morrissette M, Zeruto CA: Interrelationships of added sugars intake, socioeconomic status, and race/ethnicity in adults in the United States: National Health Interview Survey, 2005. J Am Diet Assoc. 2009, 109 (8): 1376-1383. 10.1016/j.jada.2009.05.002.CrossRefPubMedPubMedCentral
19.
go back to reference Misra D, Zhu Y, Zhang Y, Choi HK: The independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study. Semin Arthritis Rheu. 2011, 41 (3): 471-476. 10.1016/j.semarthrit.2011.02.002.CrossRef Misra D, Zhu Y, Zhang Y, Choi HK: The independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study. Semin Arthritis Rheu. 2011, 41 (3): 471-476. 10.1016/j.semarthrit.2011.02.002.CrossRef
20.
go back to reference Cohen E, Krause I, Fraser A, Goldberg E, Garty M: Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. Isr Med Assoc J. 2012, 14 (11): 676-680.PubMed Cohen E, Krause I, Fraser A, Goldberg E, Garty M: Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. Isr Med Assoc J. 2012, 14 (11): 676-680.PubMed
21.
go back to reference Lee JM, Kim HC, Cho HM, Oh SM, Choi DP, Suh I: Association between serum uric acid level and metabolic syndrome. J Prev Med Public Health. 2012, 45 (3): 181-187. 10.3961/jpmph.2012.45.3.181.CrossRefPubMedPubMedCentral Lee JM, Kim HC, Cho HM, Oh SM, Choi DP, Suh I: Association between serum uric acid level and metabolic syndrome. J Prev Med Public Health. 2012, 45 (3): 181-187. 10.3961/jpmph.2012.45.3.181.CrossRefPubMedPubMedCentral
22.
go back to reference Zhu Y, Pandya BJ, Choi HK: Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008. Am J Med. 2012, 125 (7): 679-687. 10.1016/j.amjmed.2011.09.033. e671CrossRefPubMed Zhu Y, Pandya BJ, Choi HK: Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008. Am J Med. 2012, 125 (7): 679-687. 10.1016/j.amjmed.2011.09.033. e671CrossRefPubMed
23.
go back to reference Yelken B, Caliskan Y, Gorgulu N, Altun I, Yilmaz A, Yazici H, Oflaz H, Yildiz A: Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol. 2012, 77 (4): 275-282. 10.5414/CN107352.CrossRefPubMed Yelken B, Caliskan Y, Gorgulu N, Altun I, Yilmaz A, Yazici H, Oflaz H, Yildiz A: Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol. 2012, 77 (4): 275-282. 10.5414/CN107352.CrossRefPubMed
24.
go back to reference Melendez-Ramirez G, Perez-Mendez O, Lopez-Osorio C, Kuri-Alfaro J, Espinola-Zavaleta N: Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia. Endocr Res. 2012, 37 (1): 1-6. 10.3109/07435800.2011.566235.CrossRefPubMed Melendez-Ramirez G, Perez-Mendez O, Lopez-Osorio C, Kuri-Alfaro J, Espinola-Zavaleta N: Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia. Endocr Res. 2012, 37 (1): 1-6. 10.3109/07435800.2011.566235.CrossRefPubMed
25.
go back to reference Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ: A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011, 6 (8): 1887-1894. 10.2215/CJN.11451210.CrossRefPubMedPubMedCentral Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ: A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011, 6 (8): 1887-1894. 10.2215/CJN.11451210.CrossRefPubMedPubMedCentral
26.
go back to reference Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A, Arroyo D, Luno J: Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010, 5 (8): 1388-1393. 10.2215/CJN.01580210.CrossRefPubMedPubMedCentral Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A, Arroyo D, Luno J: Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010, 5 (8): 1388-1393. 10.2215/CJN.01580210.CrossRefPubMedPubMedCentral
27.
go back to reference Wei L, Mackenzie IS, Chen Y, Struthers AD, MacDonald TM: Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol. 2011, 71 (4): 600-607. 10.1111/j.1365-2125.2010.03887.x.CrossRefPubMedPubMedCentral Wei L, Mackenzie IS, Chen Y, Struthers AD, MacDonald TM: Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol. 2011, 71 (4): 600-607. 10.1111/j.1365-2125.2010.03887.x.CrossRefPubMedPubMedCentral
28.
go back to reference Gaffo AL, Saag KG: Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?. Am J Cardiovasc Drugs. 2012, 12 (1): 1-6. 10.2165/11594580-000000000-00000.CrossRefPubMed Gaffo AL, Saag KG: Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?. Am J Cardiovasc Drugs. 2012, 12 (1): 1-6. 10.2165/11594580-000000000-00000.CrossRefPubMed
29.
go back to reference Nakaya I, Namikoshi T, Tsuruta Y, Nakata T, Shibagaki Y, Onishi Y, Fukuhara S: Management of asymptomatic hyperuricaemia in patients with chronic kidney disease by Japanese nephrologists: a questionnaire survey. Nephrology (Carlton). 2011, 16 (5): 518-521. 10.1111/j.1440-1797.2011.01446.x.CrossRef Nakaya I, Namikoshi T, Tsuruta Y, Nakata T, Shibagaki Y, Onishi Y, Fukuhara S: Management of asymptomatic hyperuricaemia in patients with chronic kidney disease by Japanese nephrologists: a questionnaire survey. Nephrology (Carlton). 2011, 16 (5): 518-521. 10.1111/j.1440-1797.2011.01446.x.CrossRef
30.
go back to reference The ARIC investigators: The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989, 129 (4): 687-702. The ARIC investigators: The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989, 129 (4): 687-702.
31.
go back to reference Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ: Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol. 1996, 6 (4): 331-340. 10.1016/S1047-2797(96)00052-X.CrossRefPubMed Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ: Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol. 1996, 6 (4): 331-340. 10.1016/S1047-2797(96)00052-X.CrossRefPubMed
32.
go back to reference Eckfeldt JH, Chambless LE, Shen YL: Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med. 1994, 118 (5): 496-500.PubMed Eckfeldt JH, Chambless LE, Shen YL: Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med. 1994, 118 (5): 496-500.PubMed
33.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612. 10.7326/0003-4819-150-9-200905050-00006.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612. 10.7326/0003-4819-150-9-200905050-00006.CrossRefPubMedPubMedCentral
34.
go back to reference Zou G: A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004, 159 (7): 702-706. 10.1093/aje/kwh090.CrossRefPubMed Zou G: A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004, 159 (7): 702-706. 10.1093/aje/kwh090.CrossRefPubMed
35.
go back to reference Gaffo AL, Jacobs DR, Lewis CE, Mikuls TR, Saag KG: Association between being African-American, serum urate levels, and the risk of developing hyperuricemia: findings from the coronary artery risk development in young adults (CARDIA) cohort. Arthritis Res Ther. 2012, 14 (1): R4-10.1186/ar3552.CrossRefPubMedPubMedCentral Gaffo AL, Jacobs DR, Lewis CE, Mikuls TR, Saag KG: Association between being African-American, serum urate levels, and the risk of developing hyperuricemia: findings from the coronary artery risk development in young adults (CARDIA) cohort. Arthritis Res Ther. 2012, 14 (1): R4-10.1186/ar3552.CrossRefPubMedPubMedCentral
36.
go back to reference Shiraishi H, Une H: The effect of the interaction between obesity and drinking on hyperuricemia in Japanese male office workers. J Epidemiol. 2009, 19 (1): 12-16. 10.2188/jea.JE20080016.CrossRefPubMedPubMedCentral Shiraishi H, Une H: The effect of the interaction between obesity and drinking on hyperuricemia in Japanese male office workers. J Epidemiol. 2009, 19 (1): 12-16. 10.2188/jea.JE20080016.CrossRefPubMedPubMedCentral
37.
go back to reference Liang MH, Fries JF: Asymptomatic hyperuricemia: the case for conservative management. Ann Intern Med. 1978, 88 (5): 666-670. 10.7326/0003-4819-88-5-666.CrossRefPubMed Liang MH, Fries JF: Asymptomatic hyperuricemia: the case for conservative management. Ann Intern Med. 1978, 88 (5): 666-670. 10.7326/0003-4819-88-5-666.CrossRefPubMed
38.
go back to reference Reunanen A, Takkunen H, Knekt P, Aromaa A: Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl. 1982, 668: 49-59.PubMed Reunanen A, Takkunen H, Knekt P, Aromaa A: Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl. 1982, 668: 49-59.PubMed
39.
go back to reference Zafrir B, Goren Y, Paz H, Wolff R, Salman N, Merhavi D, Lavi I, Lewis BS, Amir O: Risk score model for predicting mortality in advanced heart failure patients followed in a heart failure clinic. Congest Heart Fail. 2012, 18 (5): 254-261. 10.1111/j.1751-7133.2012.00286.x.CrossRefPubMed Zafrir B, Goren Y, Paz H, Wolff R, Salman N, Merhavi D, Lavi I, Lewis BS, Amir O: Risk score model for predicting mortality in advanced heart failure patients followed in a heart failure clinic. Congest Heart Fail. 2012, 18 (5): 254-261. 10.1111/j.1751-7133.2012.00286.x.CrossRefPubMed
40.
go back to reference Wiener RC, Shankar A: Association between Serum Uric Acid Levels and Sleep Variables: Results from the National Health and Nutrition Survey 2005–2008. Int J Inflam. 2012, 2012: 363054-CrossRefPubMedPubMedCentral Wiener RC, Shankar A: Association between Serum Uric Acid Levels and Sleep Variables: Results from the National Health and Nutrition Survey 2005–2008. Int J Inflam. 2012, 2012: 363054-CrossRefPubMedPubMedCentral
41.
go back to reference Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Nagahama K, Sakima A, Iseki K, Ohya Y: An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res. 2012, 36 (1): 43-49.CrossRefPubMed Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Nagahama K, Sakima A, Iseki K, Ohya Y: An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res. 2012, 36 (1): 43-49.CrossRefPubMed
42.
go back to reference Ito S, Naritomi H, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N: Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Hypertens Res. 2012, 35 (8): 867-873. 10.1038/hr.2012.59.CrossRefPubMedPubMedCentral Ito S, Naritomi H, Ogihara T, Shimada K, Shimamoto K, Tanaka H, Yoshiike N: Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Hypertens Res. 2012, 35 (8): 867-873. 10.1038/hr.2012.59.CrossRefPubMedPubMedCentral
43.
go back to reference Takayama S, Kawamoto R, Kusunoki T, Abe M, Onji M: Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovasc Diabetol. 2012, 11: 2-10.1186/1475-2840-11-2.CrossRefPubMedPubMedCentral Takayama S, Kawamoto R, Kusunoki T, Abe M, Onji M: Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovasc Diabetol. 2012, 11: 2-10.1186/1475-2840-11-2.CrossRefPubMedPubMedCentral
44.
go back to reference Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA: Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider. Am J Kidney Dis. 2011, 58 (3): 398-408. 10.1053/j.ajkd.2011.04.025.CrossRefPubMed Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA: Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider. Am J Kidney Dis. 2011, 58 (3): 398-408. 10.1053/j.ajkd.2011.04.025.CrossRefPubMed
45.
go back to reference Seki S, Tsutsui K, Fujii T, Yamazaki K, Anzawa R, Yoshimura M: Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension. Clin Exp Hypertens. 2010, 32 (5): 270-277. 10.3109/10641960903265220.CrossRefPubMed Seki S, Tsutsui K, Fujii T, Yamazaki K, Anzawa R, Yoshimura M: Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension. Clin Exp Hypertens. 2010, 32 (5): 270-277. 10.3109/10641960903265220.CrossRefPubMed
46.
go back to reference Wen CP, David Cheng TY, Chan HT, Tsai MK, Chung WS, Tsai SP, Wahlqvist ML, Yang YC, Wu SB, Chiang PH: Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk. Am J Kidney Dis. 2010, 56 (2): 273-288. 10.1053/j.ajkd.2010.01.024.CrossRefPubMed Wen CP, David Cheng TY, Chan HT, Tsai MK, Chung WS, Tsai SP, Wahlqvist ML, Yang YC, Wu SB, Chiang PH: Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk. Am J Kidney Dis. 2010, 56 (2): 273-288. 10.1053/j.ajkd.2010.01.024.CrossRefPubMed
47.
go back to reference Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS, Kuo CT: Association between endothelial dysfunction and hyperuricaemia. Rheumatology (Oxford). 2010, 49 (10): 1929-1934. 10.1093/rheumatology/keq184.CrossRef Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS, Kuo CT: Association between endothelial dysfunction and hyperuricaemia. Rheumatology (Oxford). 2010, 49 (10): 1929-1934. 10.1093/rheumatology/keq184.CrossRef
48.
go back to reference Hamaguchi S, Furumoto T, Tsuchihashi-Makaya M, Goto K, Goto D, Yokota T, Kinugawa S, Yokoshiki H, Takeshita A, Tsutsui H: Hyperuricemia predicts adverse outcomes in patients with heart failure. Int J Cardiol. 2011, 151 (2): 143-147. 10.1016/j.ijcard.2010.05.002.CrossRefPubMed Hamaguchi S, Furumoto T, Tsuchihashi-Makaya M, Goto K, Goto D, Yokota T, Kinugawa S, Yokoshiki H, Takeshita A, Tsutsui H: Hyperuricemia predicts adverse outcomes in patients with heart failure. Int J Cardiol. 2011, 151 (2): 143-147. 10.1016/j.ijcard.2010.05.002.CrossRefPubMed
49.
go back to reference Shah A, Keenan RT: Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?. Curr Rheumatol Rep. 2010, 12 (2): 118-124. 10.1007/s11926-010-0084-3.CrossRefPubMed Shah A, Keenan RT: Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?. Curr Rheumatol Rep. 2010, 12 (2): 118-124. 10.1007/s11926-010-0084-3.CrossRefPubMed
50.
go back to reference Kuo CF, Yu KH, Luo SF, Ko YS, Wen MS, Lin YS, Hung KC, Chen CC, Lin CM, Hwang JS: Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study. Rheumatology (Oxford). 2010, 49 (6): 1189-1196. 10.1093/rheumatology/keq095.CrossRef Kuo CF, Yu KH, Luo SF, Ko YS, Wen MS, Lin YS, Hung KC, Chen CC, Lin CM, Hwang JS: Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study. Rheumatology (Oxford). 2010, 49 (6): 1189-1196. 10.1093/rheumatology/keq095.CrossRef
51.
go back to reference Feig DI, Soletsky B, Johnson RJ: Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008, 300 (8): 924-932. 10.1001/jama.300.8.924.CrossRefPubMedPubMedCentral Feig DI, Soletsky B, Johnson RJ: Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008, 300 (8): 924-932. 10.1001/jama.300.8.924.CrossRefPubMedPubMedCentral
52.
go back to reference Soletsky B, Feig DI: Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents. Hypertension. 2012, 60 (5): 1148-1156. 10.1161/HYPERTENSIONAHA.112.196980.CrossRefPubMed Soletsky B, Feig DI: Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents. Hypertension. 2012, 60 (5): 1148-1156. 10.1161/HYPERTENSIONAHA.112.196980.CrossRefPubMed
53.
go back to reference Nishida Y, Akaoka I, Nishizawa T: Effect of sex hormones on uric acid metabolism in rats. Experientia. 1975, 31 (10): 1134-1135. 10.1007/BF02326752.CrossRefPubMed Nishida Y, Akaoka I, Nishizawa T: Effect of sex hormones on uric acid metabolism in rats. Experientia. 1975, 31 (10): 1134-1135. 10.1007/BF02326752.CrossRefPubMed
54.
go back to reference Numakura K, Satoh S, Tsuchiya N, Saito M, Maita S, Obara T, Tsuruta H, Inoue T, Narita S, Horikawa Y: Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival. Transplantation. 2012, 94 (2): 145-151. 10.1097/TP.0b013e318254391b.CrossRefPubMed Numakura K, Satoh S, Tsuchiya N, Saito M, Maita S, Obara T, Tsuruta H, Inoue T, Narita S, Horikawa Y: Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival. Transplantation. 2012, 94 (2): 145-151. 10.1097/TP.0b013e318254391b.CrossRefPubMed
Metadata
Title
Risk factors for incident hyperuricemia during mid-adulthood in African American and White men and women enrolled in the ARIC cohort study
Authors
Mara A McAdams-DeMarco
Andrew Law
Janet W Maynard
Josef Coresh
Alan N Baer
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2013
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-14-347

Other articles of this Issue 1/2013

BMC Musculoskeletal Disorders 1/2013 Go to the issue